Bowel cancer breakthrough may benefit thousands of patients

18 julio 2014

A significant breakthrough has been made that may benefit patients with bowel cancer. Researchers have discovered how two genes cause bowel cancer cells to become resistant to treatments used against the disease. The activity of the two genes, called MEK and MET, was uncovered when the researchers looked at all the different pathways and interactions taking place in bowel cancer cells.